{
    "2020-06-01": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Strong Pharmaceutical and Biotech Stocks to Buy for Coronavirus Immunity",
                "features": {
                    "keywords": [
                        "Pharmaceutical",
                        "Biotech",
                        "Coronavirus",
                        "Immunity"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-10",
                "original_text": "AbbVie Unveils Deal for Potential Tumor-Fighting Drug",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Deal",
                        "Tumor-Fighting",
                        "Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-24",
                "original_text": "AbbVie Gets FDA Nod for Oriahnn to Control Menstrual Bleeding",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "FDA",
                        "Oriahnn",
                        "Menstrual Bleeding"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-15",
                "original_text": "AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "FDA",
                        "EMA",
                        "RINVOQ",
                        "Psoriatic Arthritis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-01",
                "original_text": "Lilly's Cyramza Gets FDA Approval for First-Line Lung Cancer",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Cyramza",
                        "FDA",
                        "Approval",
                        "Lung Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-21",
                "original_text": "AbbVie Wrapped Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Allergan",
                        "Buyout",
                        "Stock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-15",
                "original_text": "Allergan Aesthetics Launches Dedicated Multi-Channel Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL® Recall And To Improve Tracking Information For U.S. Breast Implant Patients",
                "features": {
                    "keywords": [
                        "Allergan",
                        "BIOCELL",
                        "Recall",
                        "Breast Implant"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "aesthetics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-01-10",
                "original_text": "Drugmaker Abbvie Teams Up With Jacobio To Develop Cancer Inhibitor",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "Jacobio",
                        "Cancer",
                        "Inhibitor"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-01-15",
                "original_text": "AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Jacobio",
                        "SHP2",
                        "Inhibitors"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}